Digestive Care, Inc.   Report issue

For profit Phase 4
Founded: Bethlehem PA United States (1990)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2007
NCT00432861
First Marketed Drug
2012
pancrelipase (creon)
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Digestive Care, Inc. | DIGESTIVE CARE INC

Active Ingredients

Marketed Drugs (3)

amylase (2012)

lipase (2012)

pancrelipase (creon) (2012)

Drugs in Phase 4 Trials (1)

pancrelipase (creon) (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystic Fibrosis (Phase 4)

Exocrine Pancreatic Insufficiency (Phase 4)

Fibrosis (Phase 4)

Pancreatic Neoplasms (Phase 2)

Pancreatitis (Phase 4)

Pancreatitis, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 1